Planet 13 Holdings (PLNH) Cash from Investing Activities (2021 - 2026)
Planet 13 Holdings (PLNH) posted quarterly Cash from Investing Activities of $854829.0 for Q1 2026, up 131.76% year-over-year from $368837.5 in Q1 2025, and down 57.58% quarter-over-quarter from $2.0 million in Q4 2025.
Planet 13 Holdings (PLNH) Cash from Investing Activities (2021 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has reported Cash from Investing Activities for 6 consecutive years, with $854829.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Investing Activities rose 131.76% year-over-year to $854829.0; the TTM figure through Mar 2026 stood at $6.1 million (up 271.91% YoY), while the FY2025 annual figure was $2.5 million, up 166.82% from the prior year.
- Cash from Investing Activities fell to $854829.0 in Q1 2026 per PLNH's latest filing, from $2.0 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $5.5 million in Q3 2025 and bottomed at -$7.7 million in Q2 2022.
- Historically, Cash from Investing Activities has averaged -$1.4 million across 5 years, with a median of -$2.4 million in 2023.
- Annual changes were most pronounced in 2024 — Cash from Investing Activities jumped 1206.36% — and 2025, when it sank 154.63%.
- Planet 13 Holdings' Cash from Investing Activities stood at -$1.0 million in 2022, then sank by 128.71% to -$2.4 million in 2023, then slipped by 8.44% to -$2.5 million in 2024, then soared by 179.05% to $2.0 million in 2025, then plunged by 57.58% to $854829.0 in 2026.
- Business Quant data shows PLNH's Cash from Investing Activities at $854829.0 in Q1 2026, $2.0 million in Q4 2025, and $5.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | -491.00 Mn |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | -300.00 Mn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | -550.24 Mn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 87.50 Mn |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | -51.60 Mn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | -135.40 Mn |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | -110.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Planet 13 Holdings | 47.95 Mn | 31.46 Mn | 12.32 Mn | -378,029.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -378,029.00 |
| Jun 30, 2026 | -378,029.00 |
| Mar 31, 2026 | 854,829.00 |
| Mar 31, 2026 | 854,829.00 |
| Dec 31, 2025 | 2.01 Mn |
| Dec 31, 2025 | 2.01 Mn |
| Sep 30, 2025 | 5.48 Mn |
| Sep 30, 2025 | 5.48 Mn |
| Jun 30, 2025 | -2.28 Mn |
| Jun 30, 2025 | -2.28 Mn |
| Mar 31, 2025 | -2.69 Mn |
| Mar 31, 2025 | -2.69 Mn |
| Dec 31, 2024 | -2.55 Mn |
| Dec 31, 2024 | -2.55 Mn |
| Sep 30, 2024 | -2.46 Mn |
| Sep 30, 2024 | -2.46 Mn |
| Jun 30, 2024 | 4.17 Mn |
| Jun 30, 2024 | 4.17 Mn |
| Mar 31, 2024 | -2.94 Mn |
| Mar 31, 2024 | -2.94 Mn |